CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD.
Am J Respir Crit Care Med
; 207(12): 1576-1590, 2023 06 15.
Article
in En
| MEDLINE
| ID: mdl-37219322
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Emphysema
/
Pulmonary Disease, Chronic Obstructive
/
Emphysema
Limits:
Humans
Language:
En
Journal:
Am J Respir Crit Care Med
Journal subject:
TERAPIA INTENSIVA
Year:
2023
Type:
Article
Affiliation country:
Germany